Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 8, 2019 Off

Data Showing Potential for Machine Learning to Advance Understanding of Nonalcoholic Steatohepatitis (NASH) Presented at the Liver Meeting® 2019

By BusinessWire

— AI-Based Tools for Liver Histology Assessment Contribute to Gilead’s Broader Efforts to Improve Understanding of NASH — — Data…

November 8, 2019 Off

Fractyl Announces Revita-2 Data Showing Revita DMR Provides Statistically Significant Improvements in Blood Glucose and Liver Fat in Type 2 Diabetes with and without NAFLD

By BusinessWire

LEXINGTON, Mass.–(BUSINESS WIRE)–#LiverMtg19–Fractyl Laboratories Inc. (Fractyl) today announced positive results from the Revita-2 trial evaluating Revita DMR (duodenal mucosal resurfacing)…

November 8, 2019 Off

Codiak Presents New Preclinical Data for First-in-Class Exosome Therapeutic Candidates, exoIL-12 and exoSTING, Demonstrating Potent Anti-Tumor Activity

By BusinessWire

– exoIL-12 demonstrates tumor-retained and dose-dependent pharmacology with superior anti-tumor efficacy compared to soluble recombinant IL-12 – – exoSTING shows…

November 8, 2019 Off

New Analyses from the Phase 3 HELP Study™ Open-Label Extension in Hereditary Angioedema Evaluate Efficacy and Safety of TAKHZYRO® (lanadelumab-flyo) Injection During Extended Study Treatment Period

By BusinessWire

Data Presented at the 2019 American College of Allergy, Asthma and Immunology Annual Meeting OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited…

November 8, 2019 Off

New Real-World Data Unveiled at ACAAI Indicates Comparable Clinical Practice Logistics to Implement Oral Immunotherapy and Environmental Allergy Shots

By BusinessWire

HOUSTON–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today revealed that the logistical…

November 8, 2019 Off

Alpine Immune Sciences Presents New Preclinical Data at The Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting

By BusinessWire

 Preclinical data support unique mechanism of action of ALPN-202 as a first in class conditional CD28 Agonist ALPN-202 able to…

November 8, 2019 Off

AR101 Demonstrates Consistent Efficacy and Safety in New Analysis at ACAAI Comparing PALISADE and ARTEMIS Phase 3 Clinical Data

By BusinessWire

—Despite Differing Study Designs, Patient Criteria and Geographies of the Two Landmark Clinical Trials, Results Were Consistent for AR101-Treated Patients…

November 8, 2019 Off

Gynesonics Names Kelly U. Petrucci Vice President of Healthcare Economics and Market Access

By BusinessWire

Joins Experienced Team to Accelerate Global Launch of the new Sonata® 2 System REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, a women’s healthcare…

November 8, 2019 Off

Horizon Discovery Divests Animal Models Business to Envigo

By BusinessWire

Animal model operations to be transferred to Envigo ownership Divestment in line with Horizon’s corporate strategy to focus on its…

November 8, 2019 Off

Exelixis’ Collaborator Daiichi Sankyo Announces Positive Results From Phase 3 Pivotal Trial of Esaxerenone in Patients With Diabetic Nephropathy

By BusinessWire

— Results being presented today in a late-breaking presentation (abstract TH-PO1201) at Kidney Week 2019, the annual meeting of the…

Posts pagination

Previous 1 … 5,354 5,355 5,356 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine